FTH
FTH clinical trials: Faeth Therapeutics, Inc.
Every trial on ClinicalTrials.gov where Faeth Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 6
- Trials linked
- 6
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
FTH on the catalyst calendar · FTH registry changes
- Primary completion May 2029Sponsor estimatePhase 1/Phase 2NCT07558733Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast CancerFaeth Therapeutics · HR+ HER2- Breast CancerRecruitingFTHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 30, 2025ActualPhase 1NCT05300048Combination of Serabelisib and Insulin Suppressing Diet With or Without Nab-paclitaxel in Subjects With Advanced Solid Tumors With...Faeth Therapeutics · Advanced Solid TumorTerminatedFTHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2028Sponsor estimatePhase 2NCT06463028Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With...Faeth Therapeutics · Endometrial CancerRecruitingFTHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 10, 2025ActualNo phase registeredNCT05078775Medical Food for the Dietary Management of Advanced/Metastatic Pancreatic CancerFaeth Therapeutics · Metastatic Pancreatic AdenocarcinomaCompletedFTHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 24, 2023ActualPhase 2NCT05275673A Study of Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung CancerFaeth Therapeutics · Non-Small Cell Lung CancerTerminatedFTHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 27, 2023ActualNo phase registeredNCT05183295Medical Food for the Dietary Management of Metastatic Colorectal CancerFaeth Therapeutics · Metastatic Colorectal CancerWithdrawnFTHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 6 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner